Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France.

Trial Profile

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Candesartan cilexetil (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms SISTOLA
  • Sponsors AstraZeneca
  • Most Recent Events

    • 12 Jul 2010 Actual end date changed from May 2009 to Jun 2010 as reported by ClinicalTrials.gov.
    • 10 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top